Advertisement
Advertisement

CTKB

CTKB logo

Cytek Biosciences, Inc. Common Stock

3.68
USD
Sponsored
-0.36
-8.91%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

3.72

+0.04
+1.09%

Cytek Biosciences, Inc. Common Stock Profile

About

Cytek Biosciences Inc provides cell analysis solutions. The company developed high-resolution, high-content and high-sensitivity cell analysis technology called Full Spectrum Profiling. Cytek Biosciences Inc is based in FREMONT, Calif.

Info & Links

CEO

Wenbin Jiang

Headquarters

47215 Lakeview Blvd.
Fremont, CA 94538, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://cytekbio.com

Auditor

Deloitte & Touche LLP

Share holders

15

Employees

702

Cytek Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

480.41M

Enterprise Value

390.08M

Enterprise Value/EBITDA(ttm)

-13.73

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.93

Price to Book(mrq)

1.73

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

51.64%

Operating Margin(ttm)

-14.11%

Profit Margin(ttm)

-30.29%

Return on Equity(ttm)

-7.70%

Return on Invested Capital(ttm)

-18.79%

Return on Assets(ttm)

-5.89%

Income Statement

Revenue(ttm)

201.49M

Revenue Per Share(ttm)

1.57

Gross Profit(ttm)

104.46M

EBITDA(ttm)3

-28.41M

Net Income Available to Common(ttm)

-66.54M

Diluted EPS(ttm)

-0.51

Share Statistics

Beta (5Y Monthly)

1.28

52-Week Change

23.49%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

128.55M

Dividend Yield

0.00%

Float4

114.66M

% Held by Insiders

10.33%

% Held by Institutions

69.46%

Balance Sheet

Total Cash(mrq)

261.53M

Total Cash Per Share(mrq)

2.03

Total Debt(mrq)

525.00K

Total Debt/Equity(mrq)

0.15%

Current Ratio(mrq)

5.04%

Quick Ratio(mrq)

4.42%

Book Value Per Share(mrq)

2.66

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.04

Free Cash Flow(ytd)

-8.52M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement